310 related articles for article (PubMed ID: 16933201)
1. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J
Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
[TBL] [Abstract][Full Text] [Related]
2. Transient neutropenia induced by clozapine.
Hummer M; Kurz M; Barnas C; Fleischhacker WW
Psychopharmacol Bull; 1992; 28(3):287-90. PubMed ID: 1480732
[TBL] [Abstract][Full Text] [Related]
3. Clozapine-associated agranulocytosis: risk and aetiology.
Krupp P; Barnes P
Br J Psychiatry Suppl; 1992 May; (17):38-40. PubMed ID: 1418887
[TBL] [Abstract][Full Text] [Related]
4. Descriptive epidemiology of agranulocytosis.
Strom BL; Carson JL; Schinnar R; Snyder ES; Shaw M
Arch Intern Med; 1992 Jul; 152(7):1475-80. PubMed ID: 1627027
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin-induced neutropenia.
Mackett RL; Guay DR
Can Med Assoc J; 1985 Jan; 132(1):39-40. PubMed ID: 3965060
[TBL] [Abstract][Full Text] [Related]
6. [Frequent cases of agranulocytosis due to clozapin (leponex) in eastern Switzerland].
Jungi WF; Fischer J; Senn HJ; Hartlapp J; Pöldinger W; Kunz H; Krupp P
Schweiz Med Wochenschr; 1977 Dec; 107(49):1861-4. PubMed ID: 929152
[TBL] [Abstract][Full Text] [Related]
7. Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring: Can the regulations be relaxed?
Schulte PFJ; Veerman SRT; Bakker B; Bogers JPAM; Jongkind A; Cohen D
Schizophr Res; 2024 Jun; 268():74-81. PubMed ID: 37770377
[TBL] [Abstract][Full Text] [Related]
8. [Agranulocytosis caused by clozapine].
Kok RC; Veenhoven WA; Hoogschagen MJ
Ned Tijdschr Geneeskd; 1992 Apr; 136(16):795-6. PubMed ID: 1574151
[TBL] [Abstract][Full Text] [Related]
9. Clozapine-Associated Agranulocytosis: A Systematic Review. Is It Really So Frighteningly Common?
Magistri C; Mellini C
J Clin Psychopharmacol; 2023 Nov-Dec 01; 43(6):527-533. PubMed ID: 37930206
[TBL] [Abstract][Full Text] [Related]
10. Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs.
Lieberman JA; Johns CA; Kane JM; Rai K; Pisciotta AV; Saltz BL; Howard A
J Clin Psychiatry; 1988 Jul; 49(7):271-7. PubMed ID: 3391979
[TBL] [Abstract][Full Text] [Related]
11. Development of the Clozaril Patient Management System.
Bastani B; Alphs LD; Meltzer HY
Psychopharmacology (Berl); 1989; 99 Suppl():S122-5. PubMed ID: 2813664
[TBL] [Abstract][Full Text] [Related]
12. [Perazine-induced agranulocytosis--case report and discussion].
Hörner W; Ehninger G; Gaertner HJ
Psychiatr Prax; 1985 Jan; 12(1):23-4. PubMed ID: 2858899
[TBL] [Abstract][Full Text] [Related]
13. Agranulocytosis and significant leucopenia with neuroleptic drugs: results from the AMUP program.
Grohmann R; Schmidt LG; Spiess-Kiefer C; Rüther E
Psychopharmacology (Berl); 1989; 99 Suppl():S109-12. PubMed ID: 2573103
[TBL] [Abstract][Full Text] [Related]
14. Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland.
Rubio JM; Kane JM; Tanskanen A; Tiihonen J; Taipale H
Lancet Psychiatry; 2024 Jun; 11(6):443-450. PubMed ID: 38697177
[TBL] [Abstract][Full Text] [Related]
15. Current practice for clozapine-induced leukopenia in Japanese psychiatric hospitals: A nationwide survey.
Niitsu T; Yasui-Furukori N; Inada K; Kanazawa T; Iyo M; Ueno T; Hashimoto R
Schizophr Res; 2024 Jun; 268():82-87. PubMed ID: 38038428
[TBL] [Abstract][Full Text] [Related]
16. Agranulocytosis during treatment with chlozapine.
Idänpään-Heikkilä J; Alhava E; Olkinuora M; Palva IP
Eur J Clin Pharmacol; 1977 Mar; 11(3):193-8. PubMed ID: 856603
[TBL] [Abstract][Full Text] [Related]
17. [Problem of side effects of leponex on blood (multicenter inter- national study)].
Panteleeva GP; Gamkrelidze ShA; Dikaia VI; Magalif AA; Okuneva TP; Perevozniuk AG; Shtemberg K; Filip V; German E; Zapletanek M
Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(10):70-3. PubMed ID: 1665659
[TBL] [Abstract][Full Text] [Related]
18. Clozapine: a novel antipsychotic with a controversial introduction.
Ogle MR; Miller MJ
Indiana Med; 1991 Sep; 84(9):606-10. PubMed ID: 1682361
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the Effect of the Changes in FDA Guidelines for Clozapine Monitoring.
Sultan RS; Olfson M; Correll CU; Duncan EJ
J Clin Psychiatry; 2017; 78(8):e933-e939. PubMed ID: 28742291
[TBL] [Abstract][Full Text] [Related]
20. [Neutropenia from oxacillin. 3 pediatric cases].
Teyssier G; Frappaz D; Blanc JP; Ollagnier M; Freycon F
Pediatrie; 1984 Sep; 39(6):451-4. PubMed ID: 6527920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
